D. Abrahami

First name
D.
Last name
Abrahami
Abrahami, D. ., D’Andrea, E. ., Yin, H. ., Kim, S. C., Paik, J. M., Wexler, D. ., … Patorno, E. . (2023). Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom. Diabetes Obes Metab. http://doi.org/10.1111/dom.15196
Abrahami, D. ., Pradhan, R. ., Yin, H. ., Yanofsky, R. ., McDonald, E. G., Bitton, A. ., & Azoulay, L. . (2023). Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study. Gut. http://doi.org/10.1136/gutjnl-2022-328866
Abrahami, D. ., Tesfaye, H. ., Yin, H. ., Vine, S. ., Hicks, B. ., H. Y. Yu, O. ., … Azoulay, L. . (2022). Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1174
Douros, A. ., Abrahami, D. ., Yin, H. ., H. Y. Yu, O. ., Renoux, C. ., Hudson, M. ., & Azoulay, L. . (2018). Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000000891
Abrahami, D. ., Douros, A. ., Yin, H. ., Yu, O. H., Faillie, J. L., Montastruc, F. ., … Azoulay, L. . (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k4880
Abrahami, D. ., Yin, H. ., H. Y. Yu, O. ., Pollak, M. N., & Azoulay, L. . (2018). Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000000793
Abrahami, D. ., Douros, A. ., Yin, H. ., H. Y. Yu, O. ., Renoux, C. ., Bitton, A. ., & Azoulay, L. . (2018). Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k872
Abrahami, D. ., Douros, A. ., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2019). Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc19-0849
Abrahami, D. ., McDonald, E. G., Schnitzer, M. ., & Azoulay, L. . (2020). Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study. BMJ Open. http://doi.org/10.1136/bmjopen-2020-041529
Abrahami, D. ., Renoux, C. ., Yin, H. ., Fournier, J. P., & Azoulay, L. . (2020). The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation. Thromb Haemost. http://doi.org/10.1055/s-0040-1714213